284 related articles for article (PubMed ID: 36017393)
1. Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review.
Bhandari B; Rayamajhi G; Lamichhane P; Shenoy AK
Biomed Res Int; 2022; 2022():2911333. PubMed ID: 36017393
[TBL] [Abstract][Full Text] [Related]
2. A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
Serhan M; Psihogios A; Kabir N; Bota AB; Mithani SS; Smith DP; Zhu DT; Greyson D; Wilson S; Fell D; Top KA; Bettinger JA; Wilson K
Hum Vaccin Immunother; 2024 Dec; 20(1):2293550. PubMed ID: 38374618
[TBL] [Abstract][Full Text] [Related]
3. General determination of causation between Covid-19 vaccines and possible adverse events.
Hampton LM; Aggarwal R; Evans SJW; Law B
Vaccine; 2021 Mar; 39(10):1478-1480. PubMed ID: 33558107
[No Abstract] [Full Text] [Related]
4. To Study Adverse Effect following Immunization (AEFI) and COVID-19 Infection amongst COVID-19 Vaccine Benefeciaries.
N PP; S CS; F JV; B AB; A KM; T DP; N GC; R IA
J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436817
[TBL] [Abstract][Full Text] [Related]
5. Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.
Gordon SF; Virah Sawmy E; Duckworth E; Wolthuizen M; Clothier HJ; Chea M; Tenneti N; Blow N; Buttery JP; de Luca J; Korman TM; Barnes S; Slade C; Maggs C; Giles ML; Teh BW; Aboltins C; Langan KM; Van Diemen A; Crawford NW
Hum Vaccin Immunother; 2022 Nov; 18(5):2052701. PubMed ID: 35471988
[TBL] [Abstract][Full Text] [Related]
6. Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess.
Yamoah P; Mensah KB; Attakorah J; Padayachee N; Oosthuizen F; Bangalee V
Hum Vaccin Immunother; 2022 Nov; 18(6):2109365. PubMed ID: 35947052
[TBL] [Abstract][Full Text] [Related]
7. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years.
Puspitarani F; Sitaresmi MN; Ahmad RA
Front Public Health; 2022; 10():999354. PubMed ID: 36388348
[TBL] [Abstract][Full Text] [Related]
8. Safety and adverse events following COVID-19 vaccination among people with epilepsy: A cross-sectional study.
Ong MJY; Khoo CS; Lee YX; Poongkuntran V; Tang CK; Choong YJ; Hod R; Tan HJ
Epilepsia Open; 2023 Mar; 8(1):60-76. PubMed ID: 36214033
[TBL] [Abstract][Full Text] [Related]
9. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Christou-Ergos M; Wiley KE; Leask J
Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
[TBL] [Abstract][Full Text] [Related]
10. Best practice implementation on reporting of coronavirus disease 2019 vaccine adverse events following immunization in Uasin Gishu County, Kenya.
Amdany H; Koech B
JBI Evid Implement; 2023 Jun; 21(2):146-155. PubMed ID: 36545897
[TBL] [Abstract][Full Text] [Related]
11. Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India.
Parida SP; Sahu DP; Singh AK; Alekhya G; Subba SH; Mishra A; Padhy BM; Patro BK
J Med Virol; 2022 Jun; 94(6):2453-2459. PubMed ID: 35149993
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine-related adverse events following immunization in the WHO Western Pacific Region, 2021-2022.
Amarasinghe A; Cho H; Katalbas ER; Takashima Y
Western Pac Surveill Response J; 2023; 14(2):1-11. PubMed ID: 37492235
[TBL] [Abstract][Full Text] [Related]
13. Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan-and the effects of vaccine hesitancy and government policy.
Inokuma Y; Kneller R
Eur J Clin Pharmacol; 2023 Feb; 79(2):269-278. PubMed ID: 36527455
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of adverse events following immunisation in Australia annual report, 2021.
Glover C; Deng L; Larter C; Brogan C; Richardson O; Huang YA; Kay E; Macartney K; Wood N
Commun Dis Intell (2018); 2024 Jun; 48():. PubMed ID: 38926649
[TBL] [Abstract][Full Text] [Related]
15. Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China.
Lv H; Pan X; Wang Y; Liang H; Yu H
Hum Vaccin Immunother; 2022 Nov; 18(5):2083865. PubMed ID: 35820038
[TBL] [Abstract][Full Text] [Related]
16. Progress in Immunization Safety Monitoring - Worldwide, 2020-2022.
Blau EF; Balakrishnan MR; Sköld H; Santhana Gopala Krishnan RS; Lundquist P; Pal S; Gidudu JF
MMWR Morb Mortal Wkly Rep; 2023 Dec; 72(49):1321-1326. PubMed ID: 38060432
[TBL] [Abstract][Full Text] [Related]
17. Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in Nigeria.
Shragai T; Adegoke OJ; Ikwe H; Sorungbe T; Haruna A; Williams I; Okonkwo R; Onu K; Asekun A; Gberikon M; Iwara E; Abimiku A; Rufai A; Okposen B; Gidudu J; Lam E; Bolu O
BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650016
[TBL] [Abstract][Full Text] [Related]
18. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
[TBL] [Abstract][Full Text] [Related]
19. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
Jeon M; Kim J; Oh CE; Lee JY
J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
[TBL] [Abstract][Full Text] [Related]
20. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
